NanoLinea Overview
- Founded
- 2014
- Status
- Private
- Latest Deal Type
- Accelerator/Inc
- Investors
- 1
NanoLinea General Information
Description
Provider of therapeutic implant treatment for cardiac ventricular arrhythmia. The company creates medical devices based on carbon nanotube fiber technology.
Contact Information
Website
Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Primary Industry
Therapeutic Devices
Other Industries
Hospitals/Inpatient Services
Primary Office
- 2431 Shakespeare Street
- Suite 1
- Houston, TX 77030
- United States
NanoLinea Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 1. Accelerator/Incubator | 09-Mar-2015 | Completed | Startup |
NanoLinea Executive Team (2)
| Name | Title | Board Seat | Contact Info |
|---|---|---|---|
| Colin Young | Co-Founder & Chief Executive Officer | ||
| Mehdi Razavi MD | Co-Founder |
NanoLinea Investors (1)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|---|---|---|---|---|
| TMC Innovation | Accelerator/Incubator | 000 0000 | 000000 0 |